Schistosomicidal acridanone hydrazones
AssigneeHoffman-La Roche Inc.
InventorsUrs Brombacher, Marc Montavon, Hermann Bretschneider, Joachim Schantl, Wolfgang Turk
Life of this patent
Estimating the term…
Abstract
Acridanone derivatives of the formula ##STR1## wherein the dotted line is an optional bond, R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, one of the substituents R.sup.3 and R.sup.4 is hydrogen or lower alkyl and the other together with R is an additional bond and R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy, and pharmaceutically acceptable acid addition salts thereof, processes for their preparation and pharmaceutical compositions based thereon, are described. The compounds of formula I are useful as schistosomicidal agents.
Claims18
A compound of the formula ##STR13## wherein the dotted line is an optional bond. R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, one of the substituents R.sup.3 and R.sup.4 is hydrogen or lower alkyl and the other together with R is an additional bond, and R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy,
- or a pharmaceutically acceptable acid addition salt thereof.
A compound in accordance with claim 6, 10-methyl-9-acridanone (2-thiazolyl)hydrazone.
A compound selected from the group consisting of 9-acridanone (2-thiazolidinylidene)hydrazone, 9-acridanone (2-thiazolyl)hydrazone, 10-methyl-9-acridanone (2-thiazolidinylidene)hydrazone, 10-ethyl-9-acridanone (2-thiazolidinylidene)hydrazone, 9-acridanone methyl(2-thiazolinyl)hydrazone and 10-(2-methoxyethyl)-9-acridanone (2-thiazolidinylidene)hydrazone.
A schistosomicidal composition comprising an effective amount of a compound of the formula ##STR14## wherein the dotted line is an optional bond, R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, one of the substituents R.sup.3 and R.sup.4 is hydrogen or lower alkyl and the other together with R is an additional bond, and R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy,
- or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically inert carrier.
A method of treating or preventing schistosomiasis which comprises administering to a mammalian host an effective amount of a compound of the formula ##STR15## wherein the dotted line is an optional bond, R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, one of the substituents R.sup.3 and R.sup.4 is hydrogen or lower alkyl and the other together with R is an additional bond, and R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy,
- or a pharmaceutically acceptable acid addition salt thereof.
A compound of the formula ##STR16## wherein R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy, and one of R.sup.31 and R.sup.41 is hydrogen or lower alkyl and the other is hydrogen.
A compound of the formula ##STR17## wherein R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy, and one of R.sup.31 and R.sup.41 is hydrogen or lower alkyl and the other is hydrogen.
A compound of the formula ##STR18## wherein R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy, and R.sup.42 is hydrogen or lower alkyl.
A compound of the formula ##STR19## wherein R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy, one of R.sup.31 and R.sup.41 is hydrogen or lower alkyl and the other is hydrogen, and X' is a halogen atom.
A compound of the formula ##STR20## wherein R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy, R.sup.42 is hydrogen or lower alkyl, and X' is a halogen atom.
A compound of the formula ##STR21## wherein R.sup.1 is hydrogen, halogen or nitro, R.sup.2 is hydrogen or lower alkyl, R.sup.5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy, and one of R.sup.31 and R.sup.41 is hydrogen or lower alkyl and the other is hydrogen.
Dependencies are inferred from the claim text.